位置:首页 > 蛋白库 > GLF1_KLEPN
GLF1_KLEPN
ID   GLF1_KLEPN              Reviewed;         384 AA.
AC   Q48485;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   03-AUG-2022, entry version 112.
DE   RecName: Full=UDP-galactopyranose mutase;
DE            Short=UGM;
DE            EC=5.4.99.9;
DE   AltName: Full=UDP-GALP mutase;
DE   AltName: Full=Uridine 5-diphosphate galactopyranose mutase;
DE   Flags: Precursor;
GN   Name=rfbD;
OS   Klebsiella pneumoniae.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Klebsiella/Raoultella group; Klebsiella.
OX   NCBI_TaxID=573;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K20 / Serotype O1;
RX   PubMed=7559323; DOI=10.1128/jb.177.19.5411-5418.1995;
RA   Clarke B.R., Bronner D., Keenleyside W.J., Severn W.B., Richards J.C.,
RA   Whitfield C.;
RT   "Role of Rfe and RfbF in the initiation of biosynthesis of D-galactan I,
RT   the lipopolysaccharide O antigen from Klebsiella pneumoniae serotype O1.";
RL   J. Bacteriol. 177:5411-5418(1995).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, DISRUPTION PHENOTYPE, COFACTOR, AND SUBUNIT.
RC   STRAIN=K20 / Serotype O1;
RX   PubMed=9020123; DOI=10.1074/jbc.272.7.4121;
RA   Koplin R., Brisson J.R., Whitfield C.;
RT   "UDP-galactofuranose precursor required for formation of the
RT   lipopolysaccharide O antigen of Klebsiella pneumoniae serotype O1 is
RT   synthesized by the product of the rfbDKPO1 gene.";
RL   J. Biol. Chem. 272:4121-4128(1997).
RN   [3]
RP   REACTION MECHANISM.
RC   STRAIN=K20 / Serotype O1;
RX   PubMed=15133501; DOI=10.1038/nsmb772;
RA   Soltero-Higgin M., Carlson E.E., Gruber T.D., Kiessling L.L.;
RT   "A unique catalytic mechanism for UDP-galactopyranose mutase.";
RL   Nat. Struct. Mol. Biol. 11:539-543(2004).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) IN COMPLEX WITH FAD, COFACTOR, AND
RP   SUBUNIT.
RX   PubMed=15843027; DOI=10.1016/j.jmb.2005.02.057;
RA   Beis K., Srikannathasan V., Liu H., Fullerton S.W., Bamford V.A.,
RA   Sanders D.A., Whitfield C., McNeil M.R., Naismith J.H.;
RT   "Crystal structures of Mycobacteria tuberculosis and Klebsiella pneumoniae
RT   UDP-galactopyranose mutase in the oxidised state and Klebsiella pneumoniae
RT   UDP-galactopyranose mutase in the (active) reduced state.";
RL   J. Mol. Biol. 348:971-982(2005).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-383 IN COMPLEX WITH FAD AND
RP   SUBSTRATE, COFACTOR, AND SUBUNIT.
RX   PubMed=19719175; DOI=10.1021/bi901437v;
RA   Gruber T.D., Westler W.M., Kiessling L.L., Forest K.T.;
RT   "X-ray crystallography reveals a reduced substrate complex of UDP-
RT   galactopyranose mutase poised for covalent catalysis by flavin.";
RL   Biochemistry 48:9171-9173(2009).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 1-383 IN COMPLEX WITH FAD AND
RP   SUBSTRATE, AND COFACTOR.
RX   PubMed=19500588; DOI=10.1016/j.jmb.2009.05.081;
RA   Gruber T.D., Borrok M.J., Westler W.M., Forest K.T., Kiessling L.L.;
RT   "Ligand binding and substrate discrimination by UDP-galactopyranose
RT   mutase.";
RL   J. Mol. Biol. 391:327-340(2009).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1-383 IN COMPLEX WITH FAD,
RP   COFACTOR, AND SUBUNIT.
RA   Gruber T.D., Dimond M.C., Kiessling L.L., Forest K.T.;
RT   "Structure of UDP-galactopyranose mutase bound to flavin mononucleotide.";
RL   Submitted (DEC-2009) to the PDB data bank.
CC   -!- FUNCTION: Involved in the biosynthesis of the galactose-containing O-
CC       side-chain polysaccharide backbone structure of D-galactan I which is a
CC       key component of lipopolysaccharide (LPS). Catalyzes the
CC       interconversion through a 2-keto intermediate of uridine
CC       diphosphogalactopyranose (UDP-GalP) into uridine
CC       diphosphogalactofuranose (UDP-GalF) which is the biosynthetic precursor
CC       of galactofuranosyl residues. {ECO:0000269|PubMed:9020123}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=UDP-alpha-D-galactose = UDP-alpha-D-galactofuranose;
CC         Xref=Rhea:RHEA:24132, ChEBI:CHEBI:66914, ChEBI:CHEBI:66915;
CC         EC=5.4.99.9; Evidence={ECO:0000269|PubMed:9020123};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15843027, ECO:0000269|PubMed:19500588,
CC         ECO:0000269|PubMed:19719175, ECO:0000269|PubMed:9020123,
CC         ECO:0000269|Ref.7};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:15843027,
CC       ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
CC       ECO:0000269|PubMed:9020123, ECO:0000269|Ref.7};
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; LPS O-antigen
CC       biosynthesis.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15843027,
CC       ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
CC       ECO:0000269|PubMed:9020123, ECO:0000269|Ref.7}.
CC   -!- DISRUPTION PHENOTYPE: Abolishes lipopolysaccharide (LPS) biosynthesis.
CC       {ECO:0000269|PubMed:9020123}.
CC   -!- SIMILARITY: Belongs to the UDP-galactopyranose/dTDP-fucopyranose mutase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L31762; AAC98417.1; -; Genomic_DNA.
DR   RefSeq; WP_023284018.1; NZ_WTCT01000132.1.
DR   PDB; 1WAM; X-ray; 2.35 A; A=1-384.
DR   PDB; 2BI7; X-ray; 2.00 A; A=1-384.
DR   PDB; 2BI8; X-ray; 2.35 A; A=1-384.
DR   PDB; 3GF4; X-ray; 2.45 A; A/B=1-384.
DR   PDB; 3INR; X-ray; 2.30 A; A/B=1-383.
DR   PDB; 3INT; X-ray; 2.51 A; A/B=1-384.
DR   PDB; 3KYB; X-ray; 2.30 A; A/B=1-384.
DR   PDBsum; 1WAM; -.
DR   PDBsum; 2BI7; -.
DR   PDBsum; 2BI8; -.
DR   PDBsum; 3GF4; -.
DR   PDBsum; 3INR; -.
DR   PDBsum; 3INT; -.
DR   PDBsum; 3KYB; -.
DR   AlphaFoldDB; Q48485; -.
DR   SMR; Q48485; -.
DR   BRENDA; 5.4.99.9; 2814.
DR   UniPathway; UPA00281; -.
DR   EvolutionaryTrace; Q48485; -.
DR   GO; GO:0008767; F:UDP-galactopyranose mutase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009243; P:O antigen biosynthetic process; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR004379; UDP-GALP_mutase.
DR   InterPro; IPR015899; UDP-GalPyranose_mutase_C.
DR   Pfam; PF03275; GLF; 1.
DR   TIGRFAMs; TIGR00031; UDP-GALP_mutase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; Isomerase;
KW   Lipopolysaccharide biosynthesis; Signal.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..384
FT                   /note="UDP-galactopyranose mutase"
FT                   /id="PRO_0000087506"
FT   BINDING         14
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   BINDING         33..34
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   BINDING         41
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   BINDING         60..61
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   BINDING         84
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT   BINDING         151
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT   BINDING         156
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT   BINDING         160
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT   BINDING         185
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT   BINDING         219
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   BINDING         270
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT   BINDING         280
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT   BINDING         314
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT   BINDING         343
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   BINDING         349
FT                   /ligand="UDP-alpha-D-galactose"
FT                   /ligand_id="ChEBI:CHEBI:66914"
FT   BINDING         350..355
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:15843027,
FT                   ECO:0000269|PubMed:19500588, ECO:0000269|PubMed:19719175,
FT                   ECO:0000269|Ref.7"
FT   STRAND          5..9
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           13..23
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   TURN            24..26
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          28..39
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           40..42
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          44..46
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   TURN            48..50
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          53..55
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          62..65
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           67..74
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          79..81
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          86..90
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          93..98
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           101..107
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           114..124
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           135..143
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           145..151
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           153..160
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           164..166
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           169..171
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          179..181
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          189..194
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           197..206
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          211..216
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           221..226
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          227..232
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           236..239
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   TURN            240..244
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          249..261
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          263..271
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          276..283
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           284..287
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          294..305
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           319..332
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   STRAND          336..340
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           342..345
FT                   /evidence="ECO:0007829|PDB:2BI7"
FT   HELIX           352..371
FT                   /evidence="ECO:0007829|PDB:2BI7"
SQ   SEQUENCE   384 AA;  44457 MW;  B74EC65EA5B751AB CRC64;
     MKSKKILIVG AGFSGAVIGR QLAEKGHQVH IIDQRDHIGG NSYDARDSET NVMVHVYGPH
     IFHTDNETVW NYVNKHAEMM PYVNRVKATV NGQVFSLPIN LHTINQFFSK TCSPDEARAL
     IAEKGDSTIA DPQTFEEQAL RFIGKELYEA FFKGYTIKQW GMQPSELPAS ILKRLPVRFN
     YDDNYFNHKF QGMPKCGYTQ MIKSILNHEN IKVDLQREFI VEERTHYDHV FYSGPLDAFY
     GYQYGRLGYR TLDFKKFTYQ GDYQGCAVMN YCSVDVPYTR ITEHKYFSPW EQHDGSVCYK
     EYSRACEEND IPYYPIRQMG EMALLEKYLS LAENETNITF VGRLGTYRYL DMDVTIAEAL
     KTAEVYLNSL TENQPMPVFT VSVR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024